Profile data is unavailable for this security.
About the company
Swedencare publ AB is a Sweden-based company, which is mainly involved in the veterinary supplies industry. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores and pharmacies. It operates through four subsidiaries, namely SDC Distribution for Scandinavian countries, Buccosante located in France, Informpet in the United Kingdom and SwedencareUSA in the United States. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Powder, ProDen PlaqueOff Powder Cat and ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.
- Revenue in SEK (TTM)2.41bn
- Net income in SEK71.50m
- Incorporated1993
- Employees552.00
- LocationSwedencare AB (publ)Per Albin Hanssons Vag 41MALMO 214 32SwedenSWE
- Phone+46 4085933
- Websitehttps://swedencare.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Moberg Pharma AB (publ) | 820.00k | -22.56m | 1.79bn | 9.00 | -- | 1.72 | -- | 2,177.95 | -1.09 | -1.09 | 0.0379 | 21.63 | 0.0014 | -- | 0.2841 | -- | -3.81 | -- | -3.96 | -- | 60.00 | -- | -2,751.22 | -- | 1.73 | -- | 0.0073 | -- | -100.00 | -- | -34.26 | -- | -- | -- |
| Probi AB | 642.71m | 13.70m | 3.19bn | 162.00 | 232.84 | 2.25 | 28.19 | 4.96 | 1.20 | 1.20 | 56.41 | 124.20 | 0.4045 | 3.25 | 5.91 | 4,016,925.00 | 0.8624 | 4.64 | 0.9144 | 4.98 | 32.88 | 42.04 | 2.13 | 9.83 | 4.69 | -- | 0.0591 | 21.42 | 1.52 | 0.7684 | -58.60 | -26.09 | 31.01 | -- |
| Flerie AB | 108.34m | -56.48m | 3.75bn | 7.00 | -- | 1.08 | -- | 34.62 | -10.37 | -10.37 | 20.28 | 44.30 | 0.3559 | -- | -- | 15,477,000.00 | -18.55 | -37.64 | -21.24 | -41.14 | -46.98 | -450.51 | -52.13 | -454.62 | -- | -- | 0.0086 | -- | -- | 277.02 | 5.05 | -- | -- | -- |
| Swedencare AB (publ) | 2.41bn | 71.50m | 8.43bn | 552.00 | 117.88 | 1.09 | 21.98 | 3.49 | 0.4505 | 0.4505 | 15.21 | 48.80 | 0.2412 | 2.35 | 9.52 | 4,966,461.00 | 0.7144 | 1.38 | 0.7361 | 1.43 | 55.64 | 55.34 | 2.96 | 5.10 | 1.82 | 2.21 | 0.1746 | 45.33 | 27.48 | 88.16 | -37.96 | 20.24 | 30.90 | -- |
| Calliditas Therapeutics AB | 1.31bn | -524.82m | 12.36bn | 219.00 | -- | 92.11 | -- | 9.43 | -9.78 | -9.78 | 24.43 | 2.24 | 0.7541 | 3.16 | 8.97 | 6,723,169.00 | -30.19 | -26.46 | -38.05 | -30.27 | 95.01 | -- | -40.03 | -76.59 | 2.62 | -3.99 | 0.8943 | -- | 50.32 | -- | -13.08 | -- | -- | -- |
| BioGaia AB | 1.37bn | 401.72m | 12.44bn | 220.00 | 32.15 | 8.20 | 29.21 | 9.09 | 3.98 | 3.98 | 13.56 | 15.60 | 0.6749 | -- | -- | 6,520,886.00 | 19.80 | 15.47 | 22.19 | 16.93 | 73.84 | 73.30 | 29.34 | 27.70 | -- | -- | 0.00 | 104.42 | 17.44 | 11.81 | -2.25 | 11.20 | 29.27 | 28.10 |
| Vimian Group AB | 3.91bn | 92.72m | 17.90bn | 1.10k | 173.80 | 2.58 | 36.64 | 4.57 | 0.1992 | 0.1992 | 8.35 | 13.40 | 0.3354 | 2.83 | 5.69 | 3,556,942.00 | 0.867 | -- | 1.01 | -- | 47.48 | -- | 2.59 | -- | 1.19 | 2.81 | 0.3729 | -- | 17.92 | -- | 245.95 | -- | -- | -- |
| Bonesupport Holding AB | 735.16m | 288.78m | 19.65bn | 127.00 | 68.31 | 31.68 | 65.65 | 26.73 | 4.38 | 4.38 | 11.13 | 9.44 | 1.30 | 0.6001 | 4.88 | 7,001,534.00 | 51.17 | -9.08 | 62.05 | -11.28 | 92.22 | 90.25 | 39.28 | -11.65 | 3.07 | -- | 0.0239 | -- | 79.76 | 43.65 | 459.44 | -- | 18.39 | -- |
| Bavarian Nordic A/S | 10.40bn | 1.54bn | 23.32bn | 1.38k | 14.83 | 1.46 | 9.45 | 2.24 | 12.86 | 12.86 | 86.59 | 130.35 | 0.4956 | 1.74 | 9.32 | 4,816,359.00 | 7.35 | 1.21 | 8.92 | 1.48 | 60.90 | 53.72 | 14.82 | 4.06 | 1.03 | -- | 0.0427 | 0.00 | 124.14 | 69.78 | 524.66 | -- | 35.76 | -- |
| Camurus AB | 1.59bn | 223.25m | 38.70bn | 228.00 | 174.01 | 13.22 | 162.57 | 24.29 | 3.79 | 3.79 | 27.51 | 49.94 | 0.6122 | 1.09 | 4.86 | 7,480,770.00 | 8.58 | -1.13 | 10.10 | -1.41 | 92.01 | 90.05 | 14.01 | -1.63 | 7.11 | -- | 0.0071 | -- | 79.52 | 103.39 | 676.63 | -- | 16.29 | -- |
Data as of Jul 25 2024. Currency figures normalised to Swedencare AB (publ)'s reporting currency: Swedish Krona SEK
17.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| F�rsta AP-fondenas of 31 Dec 2023 | 7.63m | 4.81% |
| AMF Fonder ABas of 31 Dec 2023 | 5.37m | 3.38% |
| Grandeur Peak Global Advisors LLCas of 31 Dec 2023 | 3.39m | 2.13% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Dec 2023 | 2.17m | 1.37% |
| Deka Investment GmbHas of 31 Mar 2024 | 2.04m | 1.29% |
| SEB Investment Management ABas of 28 Jun 2024 | 1.88m | 1.18% |
| Aktia Bank Plc (Investment Management)as of 28 Jun 2024 | 1.56m | 0.99% |
| Enter Fonder ABas of 30 Jun 2023 | 1.35m | 0.85% |
| ODIN Forvaltning AS (Sweden)as of 31 Aug 2023 | 1.30m | 0.82% |
| Handelsbanken Fonder ABas of 30 Jun 2024 | 1.17m | 0.74% |
More ▼
Data from 30 Jun 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
